✦ LIBER ✦

93 RIFAXIMIN IS EFFECTIVE IN MAINTAINING REMISSION IN HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

✍ Scribed by N. Bass; K. Mullen; S. Sigal; A. Sanyal; F. Poordad; K. Merchant; S. Huang; A. Shaw; E. Bortey; W. Forbes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 RIFAXIMIN TREATMENT IMPROVED QUALITY

✍ A. Sanyal; N. Bass; K. Mullen; F. Poordad; A. Shaw; K. Merchant; E. Bortey; W.P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

207 SAFETY OF RIFAXIMIN IN PATIENTS WITH

✍ K. Mullen; S. Sigal; M. Sheikh; N. Bass; F. Poordad; K. Merchant; S. Huang; A. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Su1687 Utility of the Hepatic Encephalop

✍ Hassanein, Tarek; Barakat, Fatma; Barrett, Andrew C.; Bortey, Enoch; Paterson, C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 495 KB

66 Rifaximin Reduces the Risk of Hospita

✍ Guy Neff; Carroll B. Leevy; Todd Frederick; Kunal Merchant; Shirley Huang; Audre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Comparison of rifaximin and lactitol in

✍ Antoni Mas; Juan Rodés; Lourdes Sunyer; Luı́s Rodrigo; Ramon Planas; Victor Varg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A Randomized, Double-Blind, Controlled T

✍ Sharma, Barjesh Chander; Sharma, Praveen; Lunia, Manish Kumar; Srivastava, Siddh 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB